SUS — Surgical Science Sweden AB Share Price
0.000.00%
Last trade - 00:00- SEK7.50bn
- SEK6.89bn
- SEK884.09m
- 59
- 13
- 80
- 48
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 29.92 | ||
| PEG Ratio (f) | 0.88 | ||
| EPS Growth (f) | 51.64% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.68 | ||
| Price to Tang. Book | 9.11 | ||
| Price to Free Cashflow | 134.05 | ||
| Price to Sales | 7.92 | ||
| EV to EBITDA | 33.33 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.08% | ||
| Return on Equity | 3.11% | ||
| Operating Margin | 15.03% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 104.8 | 366.78 | 802.54 | 882.85 | 884.09 | 1,128.55 | 1,344.9 | 54.17% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -0.1 | +366.52 | +82.65 | +24.4 | -43.83 | +48.37 | +53.61 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Surgical Science Sweden AB is a Sweden-based company, which provides with virtual reality simulators for evidence based laparoscopic and endoscopic training. The systems comprise LapSim, EndoSim and TeamSim trainings. Each training combine graphics and cognitive instruction, imply navigation on touch screens and feature tactile feedback technology. The LapSim trainings consist of laparoscopic exercises that range from basic navigation to advanced suturing, the EndoSim endoscopic exercises range from functions of the scope handle and tube, to loop reduction. The TeamSim comprises procedure modules to train in a real world operation room environment and helps to build team communication skills in crisis and routine situations. The training systems are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors.
Directors
- Roland Bengtsson CHM (66)
- Gisli Hennermark CEO (49)
- Anna Ahlberg CFO (51)
- Jan Oestman CEX (54)
- Anders Larsson CTO (48)
- Jeffrey Berkley OTH (52)
- Daniel Evestedt OTH (44)
- Martin Jansson OTH (50)
- Jan Bengtsson DRC (77)
- Tommy Forsell DRC (68)
- Nils Sellbom DRC (62)
- Thomas Eklund IND (54)
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- August 1st, 1997
- Public Since
- June 19th, 2017
- No. of Shareholders
- 8,229
- No. of Employees
- 336
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 51,026,236
- Address
- Drakegatan 7, GOETEBORG, 412 50
- Web
- https://surgicalscience.com/
- Phone
- +46 317416560
- Auditors
- KPMG AB
Upcoming Events for SUS
Q3 2025 Surgical Science Sweden AB Earnings Release
Similar to SUS
Acarix AB
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
What is the Surgical Science Sweden AB share price?
As of Today at 23:31 UTC, shares in Surgical Science Sweden AB are trading at SEK147.00. This share price information is delayed by 15 minutes.
How has the Surgical Science Sweden AB share price performed this year?
Shares in Surgical Science Sweden AB last closed at SEK147.00 and the price had moved by +14.49% over the past 365 days. In terms of relative price strength the Surgical Science Sweden AB share price has outperformed the FTSE Global All Cap Index by +9.71% over the past year.
What are the analyst and broker recommendations for Surgical Science Sweden AB?
The overall consensus recommendation for Surgical Science Sweden AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Surgical Science Sweden AB dividend yield?
Surgical Science Sweden AB does not currently pay a dividend.
Does Surgical Science Sweden AB pay a dividend?
Surgical Science Sweden AB does not currently pay a dividend.
When does Surgical Science Sweden AB next pay dividends?
Surgical Science Sweden AB does not currently pay a dividend.
How do I buy Surgical Science Sweden AB shares?
To buy shares in Surgical Science Sweden AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Surgical Science Sweden AB?
As of the previous close price of SEK147.00, shares in Surgical Science Sweden AB had a market capitalisation of SEK7.50bn.
Where are Surgical Science Sweden AB shares listed?
Here are the trading details for Surgical Science Sweden AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: SUS
What kind of share is Surgical Science Sweden AB?
Based on an overall assessment of its quality, value and momentum Surgical Science Sweden AB is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Surgical Science Sweden AB share price forecast for 2025?
The analyst consensus target price for shares in Surgical Science Sweden AB is SEK186.40. That is 26.8% above the last closing price of SEK147.00.
Analysts covering Surgical Science Sweden AB currently have a consensus Earnings Per Share (EPS) forecast of SEK3.83 for the next financial year.
Find out moreWhat is the trend in the Surgical Science Sweden AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Surgical Science Sweden AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -12.68%.
As of the last closing price of SEK147.00, shares in Surgical Science Sweden AB were trading +1.88% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Surgical Science Sweden AB PE Ratio?
The Surgical Science Sweden AB PE ratio based on its reported earnings over the past 12 months is 29.92. The shares last closed at SEK147.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Surgical Science Sweden AB?
Surgical Science Sweden AB's management team is headed by:
- Roland Bengtsson - CHM
- Gisli Hennermark - CEO
- Anna Ahlberg - CFO
- Jan Oestman - CEX
- Anders Larsson - CTO
- Jeffrey Berkley - OTH
- Daniel Evestedt - OTH
- Martin Jansson - OTH
- Jan Bengtsson - DRC
- Tommy Forsell - DRC
- Nils Sellbom - DRC
- Thomas Eklund - IND